Icatibant Injection

For Hereditary Angioedema (HAE) Patients

Generic Icatibant Injection is an FDA-approved, fully substitutable, chemically equivalent,* and affordable option when treating acute attacks of HAE.

On-Demand Treatment
for HAE Attacks

Icatibant Injection can be used to treat all acute HAE attacks, including cutaneous, abdominal, and laryngeal attacks. It can reduce the duration and time to resolution of the attack.

vs. Generic

Icatibant Injection, manufactured by Fresenius Kabi, is less expensive, easy to use, and made with the same quality ingredients as the brand-name product.

A Trustworthy,
Reliable Source

Fresenius Kabi is a leading provider of generic medications with a 100-year history of delivering innovative therapies that are safe, efficient, and affordable.


Help Your Patients Be Prepared

The World Allergy Organization and the European Academy of Allergy and Clinical Immunology recommend patients be ready to manage their disease by keeping two on-demand HAE treatments with them at all times.